subpage banner


Image for Revolutionizing Treatment: Gain Therapeutics Leads the Way in AI-Driven Drug Discovery for Complex Diseases

Watch Gain Therapeutics’ Cantor Fitzgerald Healthcare Conference Presentation



On September 30th, 2021 Gain Therapeutics presented at the Cantor Fitzgerald virtual global healthcare conference. Eric Richman, CEO and Manolo Bellotto, GM and President, sat down with Cantor equity research analyst Kristen Kluska to discuss the challenges and opportunities in addressing lysosomal storage and CNS disease. 

The presentation was held in the form of a “fireside chat”, which is essentially an informal interview between a moderator and a guest speaker or speakers. Typically, Gain Therapeutics will present a corporate slidedeck without any live interaction or feedback. The fireside chat format allows for the exploration of more specific and nuanced topics as the moderator can focus on topics of their choosing. 

What did Gain Present at the Cantor Fitzgerald Healthcare Conference? 

GANX Cantor Fitzgerald Healthcare Conference Presentation 1


In this fireside chat, Gain Therapeutics discussed topics such as the various disease areas that can be addressed by targeting protein misfolding, the advantages of targeting allosteric binding sites, the key advantages of the discovery platform and novel molecules it produces, and positive data released. Gain Therapeutics full fireside chat with Cantor can be viewed here

View Presentation


Latest Articles